Cost-effectiveness of ticagrelor in patients with type 2 diabetes and coronary artery disease with a history of PCI: an economic evaluation of THEMIS-PCI using a Swedish healthcare perpective

29 August 2020 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Using Data to Drive Policy Health Economics ESC Premium Access ESC Congress 2020

ESC 365 is supported by

ESC 365 is supported by